Device Can Detect Heart Failure Symptoms
Posted on: Thursday, 16 December 2004, 15:00 CST
MIAMI -- A device that automatically detects early symptoms of congestive heart failure has been implanted in a patient in the United States for the first time.
The device is designed to allow patients to get treatment earlier and stay healthier.
When fluid levels around the heart get too high, they can interfere with a normal heartbeat and cause death. The device implanted Monday in 70-year-old Antonio Comandari of Miami monitors the amount of fluid in the chest. If there is a buildup, doctors can prescribe medication to reduce it.
The InSync Sentry device, built by Medtronic Inc. of Fridley, Minn., is about the size of a cigarette lighter and transmits radio signals that can yield a computer readout on the heart.
The device costs about $30,000, lasts five to seven years and should be available for widespread use by February, said Comandari's physician, said Dr. Alberto Interian, chief cardiologist at Jackson Memorial Hospital.
It was approved by the Food and Drug Administration last month. About 400,000 Americans are candidates to receive the device, Interian said.
"More and more we're seeing patients who are living with severe congestive heart failure, where four or five years ago they'd be dead. Devices like this are improving the quality of life," he said.
Dr. Ann Bolger, a cardiologist with the American Heat Association, said the device could be helpful in catching problems quickly and helping people avoid hospitalization.
"The new part of this is basically implanting a remote sensor in the patient's body," Bolger said. "That is the very exciting part of this."
The device also works as a defibrillator to jump-start hearts and make them beat in a normal rhythm.
Comandari has had three heart attacks and thought the fourth was coming last week when he felt dizzy and collapsed in bed. On Dec. 9, he was admitted with congestive heart failure.
"I'm happy because I was chosen to get a new life," he said.
-----
On the Net:
Source: Associated Press/AP Online
Related Articles
- New Data Demonstrates Value of Cardiac Devices and Diagnostics in Managing Heart Failure Patients
- BioControl Medical Announces Publication of Data From the European Pilot Study of the CardioFit(TM) System for Congestive Heart Failure in the European Journal of Heart Failure
- Final Data From the SEISMIC Trial Suggest Safety, Efficacy of Autologous Stem- Cell Therapy for Treating Congestive Heart Failure
- Study Data Shows Gaps and Variation in the Use of Evidence-Based Treatments and Guidelines for Chronic Heart Failure
- Vanderbilt Enrolling Heart Failure Patients in New Pacing Device Study
- Targeted Renal Therapy With FlowMedica's Benephit(TM) Delta Infusion System Improves Kidney Function in an Experimental Model of Congestive Heart Failure: Research Presented at TCT Symposium
- An Implantable Cardioverter-Defibrillator but Not Amiodarone Reduced Risk for Death in Congestive Heart Failure/COMMENTARY
- Loyola Researchers Discover Congestive Heart Failure Biological Marker
- Protein Design Labs Reports Positive Results in Phase II Clinical Trial (SIRIUS II) of Ularitide for Decompensated Congestive Heart Failure
 |
 |
User Comments (0)
RSS Feeds